Alex Wu
Analyst · Citi. Please go ahead
Thank you, Haisheng. And hello everyone. First, let me give you a quick update on our full year financials. Our total net revenue reached RMN9.22 billion in 2019, a remarkable launch and 7% year-over-year increase and non-GAAP net income reached RMB2.75 billion in 2019, a 53% up year-on-year increase as well. We are thrilled to deliver these results, and this is a strong fit to our guidance RMB8 billion to RMB8.5 billion net revenue, announced in early 2019. These solid results further proves our capability to fully deliver our promises committed to all our stakeholders.Specifically in the fourth quarter, as Haisheng just mentioned, our stable operation translate into healthy financial results. Total net revenues increased by 53% year-over-year to RMB2.4 billion and non-GAAP net income reached RMB515 million in the same quarter. In spite of the industry turbulence during the fourth quarter, we proactively adopted a more prudent strategy and successfully carried out a series of initiatives on various operation fronts such as risk management, borrower's acquisition, fund management, etc. In summary, we're focused on two aspects. One, the increase of the operational efficiency and, two, maintain sufficient margin up to 50. In terms of operational efficiency, we witnessed a significant reduction of borrower acquisition costs, continue the decreasing trend of funding cost and enjoying a full year low effective tax rate.Firstly, we proactively refined borrower acquisition strategy and trimmed down sales and marketing expenses. The acquisition cost continue to drop to RMB228 for each new borrower with a full credit line, in comparison of RMB246 in the previous quarter. With this, we delivered the decreasing units acquisition cost in two consecutive quarters and we are confident to see the trend to continue in the first quarter of 2020.Secondly, in spite of the challenging industry environment, we successfully issued RMB1 billion of ABS with attractive all-in cost at around 5.6%. By this, our total ABS issue for the full year of 2019 reached RMB2.3 billion, with all-in cost of 5.6%. Moreover, we have expanded our co-efficient with financial institutions. The number of financial institutions working with us increased to 81 by end of 2019 in comparison of 26 by end of 2018. And thanks for all this effort, our overall funding cost slid down from 9.2% in the fourth quarter of 2018 to 8% in the fourth quarter of 2019.Thirdly, we have spend a great effort to reach a record low effective tax rate of 14.5% in 2019 in comparison to slightly higher than 20% in 2018. Again, this is a good indicator to show our sound relationship with all the regulators. In terms of the margin and safety, we're focused on maintaining a healthier leverage ratio and to proactively increase our provisions. Firstly, we continue to expand the capital-light model business which is without any risk taking. During the quarter, loan origination under the capital-light model accounted for 22% of the total loan origination volume up from 20% in the prior quarter, with a Q-on-Q increase of 27% in terms of outstanding loan balance.While our total outstanding loan balance continue to grow, the outstanding balance with risk taking business decreased to RMB58 billion from RMB59 billion last quarter. Our net equity increased by 6.9% year-over-year to RMB7.2 billion as our leverage ratio continue to decrease to 8.1 times from 8.8 times in the previous quarter. We expect that leverage ratio will continue to its downward trend in the coming quarters.Secondly, in terms of the provision, we would like to highlight that different platforms might undertake different accounting approaches. And as a result, there may not be a direct like for like benchmarking amount of it among different platforms. Our approach is to assess quality in a perspective of our entire loan life cycle and focus sufficient provision covering the whole cycle and infection of the loan origination. We add more provision this time when we see the negative impact is slightly worse than our original expectation so as to maintain four times provision coverage. More importantly before loan expire, we do not recognize any gain from over reserve provision items when asset quality turns out to be better than our original expectation. Therefore you won't see any negative numbers on any of the provision items and even on our P&L. The gain from excessive provision will be booked on the other revenue line only after loans retire.In light of the economy uncertainties and drag on the collection process, we enhance our provisions cushion for the whole outstanding loan portfolios and maintain a sufficient coverage ratio of more than four times, take into consideration of our 2020 year-to-date operation performance. Our preliminary expect a further increase of provisions due to the impact of COVID-19 situation, but we can assure you that this will be a manageable level. Furthermore, in regard to compliance, I would like to add that the contribution for our P2P funding continue to decline in the fourth quarter. As of December 31, 2019, the PDP funding dropped to 4.5% of our total loan outstanding balance. We expect that this downtrend continue in the coming quarters. Currently the credit line granted by our institutional funding partners is more than two times of our total loan origination volume, which provides easy replacement for the PDP funding. This is another solid demonstration of our sufficient and various institution of funding resources.In closing, despite the unexpected outbreak of COVID-19 and the volatile global economic conditions, our business remains stable and healthy. In the meantime, we will continue to focus on asset quality and launch our marginal safety through careful cash management and also stay alert on any minor turmoil down the road and accomplish our full-year business target in 2020. Additionally, I would like to emphasize on that our management are in firm consensus that we are facing a golden opportunity to further solidify our market leading position and remain in fullest confidence in our long-term growth prospects.Now I would like to turn the page to our CRO, Zheng Yan.